Funding Disclosures Reveal Changes in Money Flows; Biz Models, Pricing Reform Driving the Shift

By Reiji Anasako Drug makers’ R&D funding to healthcare professionals logged a near-50% drop in FY2017 compared to FY2012, according to their disclosures tallied by Jiho. What are the drivers behind this big dip? Let’s take a closer look. The...read more